Literature DB >> 17991217

Field evaluation of the efficacy of tolfenamic acid administered in one single preoperative injection for the prevention of postoperative pain in the dog.

E Grandemange1, S Fournel, B Boisramé.   

Abstract

In this randomized, placebo-controlled, blinded field trial, 62 dogs (of which four were excluded) taken to a veterinary practice for orthopaedic surgery with a postoperative painful component were enrolled to assess the efficacy of a preoperative intramuscular injection of tolfenamic acid (TA) at a dose of 4 mg/kg in preventing postoperative pain. The animals were clinically examined at T1 + 1H, T1 + 4H, T1 + 24H (T1 = extubation). The efficacy results showed a statistical effect of TA in preventing postoperative pain with the evolution in the pain statistically in favour of TA treatment (Visual Analogue Scale). This was confirmed by the sum of the scores calculated at T1 + 24H that was statistically higher in the placebo group, and by the evolution in the respiratory rate, which was statistically lower in the TA-treated animals after surgery. TA treatment was very well tolerated as no clinical sign (except one isolated case of vomiting and diarrhoea, i.e. 3.5%) or change in biochemical and haematological values was observed and as no interaction with the anaesthetic drugs and with marbofloxacin was reported.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17991217     DOI: 10.1111/j.1365-2885.2007.00899.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  3 in total

1.  Effect of tolfenamic acid on canine cancer cell proliferation, specificity protein (sp) transcription factors, and sp-regulated proteins in canine osteosarcoma, mammary carcinoma, and melanoma cells.

Authors:  H Wilson; G Chadalapaka; I Jutooru; S Sheppard; C Pfent; S Safe
Journal:  J Vet Intern Med       Date:  2012-04-27       Impact factor: 3.333

2.  Effect of Selected Nonsteroidal Anti-inflammatory Drugs on the Viability of Canine Osteosarcoma Cells of the D-17 Line: In Vitro Studies.

Authors:  Dominik Poradowski; Bożena Obmińska-Mrukowicz
Journal:  J Vet Res       Date:  2019-09-13       Impact factor: 1.744

3.  Efficacy and safety of cimicoxib in the control of perioperative pain in dogs.

Authors:  E Grandemange; S Fournel; F Woehrlé
Journal:  J Small Anim Pract       Date:  2013-06       Impact factor: 1.522

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.